J.Perinat.Med.2022;50(3):327–333
Fahad M.S. Arattu Thodika, Mahesh Nanjundappa, Theodore Dassios, Aaron Bell
and Anne Greenough*
Pulmonary hypertension in infants with
bronchopulmonary dysplasia: risk factors,
mortality and duration of hospitalisation
https://doi.org/10.1515/jpm-2021-0366 ventilation duration (OR: 26.9, 95% CI: 3.8–189.4),
ReceivedJuly26,2021;acceptedNovember16,2021; p<0.001. In infants who survived to discharge, late PH
publishedonlineDecember1,2021 developmentwasassociatedwithaprolongeddurationof
stay[147(118–189)days]comparedtotheinfantsthatdid
Abstract
not develop late PH [109 (85–149) days] (p=0.03 after
adjustingforgestationalage).InfantswhohadlatePHhad
Objectives: Pulmonary hypertension (PH) is a complica-
ahighercostofstaycomparedtoinfantswithBPDwhodid
tionofbronchopulmonarydysplasia(BPD)andassociated
notdeveloplatePH(median£113,494vs.£78,677,p=0.016
with increased mortality and morbidity. Our aim was to
afteradjustingforgestationalage).
identify,ininfantswithBPD,theeffectofPHonhealth-care
Conclusions: DevelopmentoflatePHwasassociatedwith
utilisationandhealthrelatedcostofcare.
increased mortality, a prolonged duration of stay and
Methods: Anelectronicdatarecordingsystemwasusedto
higherhealthcarecost.
identifyinfants≤32weeksofgestationwhodevelopedBPD.
PH was classified as early (≤28 days after birth) or late Keywords: bronchopulmonary dysplasia; neonate; pre-
(>28daysafterbirth). mature;pulmonaryhypertension.
Results: Inthestudyperiod,182infantsdevelopedBPD;22
(12.1%) developed late PH. Development of late PH was
associated with a lower gestational age [24.6 (23.9–26.9) Introduction
weeks, p=0.001] and a greater need for positive pressure
ventilation on day 28 after birth (100%) compared to in-
The survival rates of extremely premature infants have
fantswithoutlatePH(51.9%)(oddsratio(OR)19.5,95%CI:
improved significantly in the last few decades, but are
2.6–148),p<0.001.LatePHwasassociatedwithincreased
associated with long term morbidities [1–3]. Broncho-
mortality (36.4%) compared those who did not develop
pulmonary dysplasia (BPD) is the most common adverse
late PH (1.9%) after adjusting for gestational age and
outcomeandcanresultincomplicationswhichmayextend
intoadulthood[4].Oneofthesignificantcontributoryfac-
*Correspondingauthor:ProfessorAnneGreenough,Departmentof torsformorbidityandmortalityininfantswithBPDisthe
WomenandChildren’sHealth,SchoolofLifeCourseSciences,Faculty
developmentofpulmonaryhypertension(PH)[5].
ofLifeSciencesandMedicine,King’sCollegeLondon,London,UK;
The incidence of pulmonary hypertension in infants
AsthmaUKCentreforAllergicMechanismsinAsthma,King’sCollege
withBPDrangesfrom17to37%[6–8].Thepathogenesisof
London,London,UK;andNIHRBiomedicalResearchCentrebasedat
Guy’sandStThomas’NHSFoundationTrustandKing’sCollege pulmonary vascular diseaseassociatedwithBPD ismulti-
London,London,UK,Phone:02032993037, factorialandcanbeattributedtotheinteractionofmaternal,
E-mail:anne.greenough@kcl.ac.uk geneticandpostnatalfactors.Inhibitionofangiogenesishas
FahadM.S.ArattuThodika,DepartmentofWomenandChildren’s
been associated with decreased alveolarization and pul-
Health,SchoolofLifeCourseSciences,FacultyofLifeSciencesand
monaryvasculargrowthinananimalmodel[9].Thearrest
Medicine,King’sCollegeLondon,London,UK.
of vascular growth and the reduction in the alveolar-
https://orcid.org/0000-0002-8791-3122
MaheshNanjundappa,NeonatalIntensiveCareCentre,King’sCollege capillarysurfaceresultinimpairedgasexchange.Thus,the
HospitalNHSFoundationTrust,London,UK lungsareexposedtoprolongedventilationandhighoxygen
TheodoreDassios,DepartmentofWomenandChildren’sHealth, levelsalongwithhemodynamicandinflammatorystressors.
SchoolofLifeCourseSciences,FacultyofLifeSciencesandMedicine,
This causes pulmonary arterial remodelling leading to
King’sCollegeLondon,London,UK;andNeonatalIntensiveCare
fibrosisofthevesselwalls[10].Theriskfactorsassociated
Centre,King’sCollegeHospitalNHSFoundationTrust,London,UK
AaronBell,DepartmentofPaediatricCardiology,EvelinaChildren’s with the development of pulmonary hypertension include
Hospital,Guy’sandStThomas’NHSFoundationTrust,London,UK intrauterine growth restriction, preeclampsia, maternal
OpenAccess.©2021FahadM.S.ArattuThodikaetal.,publishedbyDeGruyter. ThisworkislicensedundertheCreativeCommonsAttribution
4.0InternationalLicense.
328 ArattuThodikaetal.:BPDandpulmonaryhypertension
substance abuse, lower gestational age and birthweight, paediatric cardiologist. The presence of PH was defined based on
patent ductus arteriosus (PDA) requiring treatment and quantitative or qualitative assessments. Quantitative assessment
sepsis[8,11–14]. includedthepresenceoftricuspidregurgitantjetvelocity(TRJV)>3m/s
(rightventricularsystolicpressure(RVSP)>36mmHg).Intheabsenceof
Thegoldstandardtodiagnosepulmonaryhypertension
tricuspidregurgitation,qualitativeassessmentwasusedtodetectPH
is cardiac catheterization, but this is often difficult to usingthefollowingparameters:(i)flattenedorleftdeviatedintraven-
performinBPDinfantswhomayhavesignificantvascular tricularseptuminventricularsystole(ii)righttoleftshuntingacrossa
and haemodynamic complications [15]. Two-dimensional patentforamenovale,atrialseptaldefect,ventricularseptaldefector
echocardiography,however,isavaluabletoolforscreening patentductusarteriosus,ifpresent(iii)rightventricularhypertrophyor
dysfunction[15].
anddiagnosisofPHinsuch patients[10].Variousstudies
have investigated the risk factors, outcomes [5–8, 11, 14,
Definitionsandriskfactors
16–21] and evolution of pulmonary hypertension in BPD
infants [7,8,14, 19–21]. The identifiedrisk factors include
BPDwasdefinedaspertheJobeandBancalaricriteria[22].EarlyPH
early pulmonary hypertension, postnatal steroid adminis-
wasdefinedasPHdiagnosedwithin28daysafterbirth,whilelatePH
tration, tracheostomy and tracheitis [5, 16, 17]. Outcomes
diagnosedafter28days[16].Severeintraventricularhaemorrhagewas
associatedwithPHinBPDinfants include increased mor- definedasGrade3or4asdescribedbyPapile[24].
tality and morbidity including a prolonged duration of The last echocardiogram during the admission was used to
invasiveventilation,increasedoccurrenceofsevereIVHand identifythepresenceofPHatdischargeordeath.Riskfactorsforlate
prolongedhospitalization[5,7,8,14,19–21].Ouraimwasto PH assessed included maternal preeclampsia, substance abuse,
smallforgestationalage(SGA)(definedasbirthweightlessthan10th
identify,ininfantswithBPD,theeffectofPHonhealth-care
percentileorlessthan−1.28standarddeviationforgestationalage
utilisationandthehealthrelatedcostofcare.
[25]), positive pressure ventilation (PPV) at 28 days after birth,
medically or surgically treated patent ductus arteriosus (PDA),
Materials and methods sepsis(positivebloodculturerequiringintravenousantibiotics)and
presenceofearlyPH.
Studysubjects
Outcomes
An observational study was conducted of infants admitted to the
Weassessedthemortalityinthecohortandthetotaldurationofstayin
neonatalunitataLondonhospital,UnitedKingdom(UK)between
thesurvivors.Additionally,thetotalcostofstaywascalculatedbased
January 2017 and December 2020. Badgernet, an electronic patient
onnationalaveragecostsofneonatalunitstay.Wealsocomparedthe
recorddatabase,wasusedtoidentifystudysubjects.Thecriteriafor
lengthandcostofstayininfantswhomPHresolvedpriortodischarge
inclusion were (i) infants born at or prior to 32 weeks’ gestation
against the ones in whom PH did not resolve prior to death or
(ii) birthweight less than 1,500 g and (iii) development of BPD
discharge. The average daily cost ranges from £437 to £1,218 was
(oxygenrequirementforatleast28daysfrombirth)[22].Infantswho
gradedbasedontheintensityofcarecodedasintensivecare,high
diedbefore36weeksofgestation,butrequiredoxygenforatleast
dependencyandspecialcare(Table1)[26].Thedurationofcareat
28dayswereincludedinthestudy[23].
eachlevelofcarewasextractedfromBadgernetandusedtoestimate
Infantshadanechocardiogramwhentherewasaclinicalsus-
thetotalcostofstayintheneonatalunit.
picion of pulmonary hypertension as evidenced by different pre-
ductal and post-ductal saturations, a persistently high oxygen
Statisticalanalysis
requirement above 60% and/or requiring increased mean airway
pressures to maintain oxygenation. Some infants had an echocar-
diogramforassessmentofwhethertheyhadapatentductusarteriosus OntestingfornormalityusingShapiro-Wilktest,thedatawasfoundto
(PDA).Infantswhoseechocardiogramreportswerenotavailable,who benon-normallydistributed.Therefore,theMann-WhitneyUtestwas
wereadmittedforshortsurgicalproceduressuchasinguinalhernia usedforcomparingthecontinuousvariablesandChi-squaretestfor
and laser photocoagulation and those with major respiratory and dichotomousvariables.Multiplelogisticorlinearregressionwasused
cardiacanomalieswereexcludedfromthestudy. toadjustforconfoundingvariables.Alltheriskfactorswereadjusted
Ethicalapproval
Table: Nationalscheduleofreferencecostsinneonatalunitsin
UK.
ThestudywasregisteredwiththelocalClinicalGovernanceandAudit
Departmentanddidnotrequireinformedparentalconsent.
Levelofintensity Nationalaverageunitcostperday
(interquartilerange)
Assessmentofpulmonaryhypertension
Intensivecare £,(£–£,)
Highdependency £(£–£)
Theechocardiogramsoftheinfantswerereviewedbyoneauthor,a
Specialcare £(£–£)
neonatologisttrainedinechocardiographyandfurtherreviewedbya
ArattuThodikaetal.:BPDandpulmonaryhypertension 329
forgestationalage,birthweightzscoreand10minApgarscore.The Table: Demographicsofthestudypopulation.
effect on mortality and duration of hospitalisation were further
adjustedforgestationalageandthedurationofinvasiveventilation. Median n(%)
Theeffectoftotalcostofstaywasfurtheradjustedforgestationalage. (interquartile
IBMSPSSStatisticsforWindows,Version25.0(SPSSInc.Chicago,IL) range)
wasusedtoanalysethedata.
Gestationalage .
(.–.)
Birthweight (–)
Results Smallforgestationalage (.)
Sex Male:(.)
Ethnicity(maternal) White:()
A total of 428 premature infants were admitted to the Black:(.)
neonatalunitduringthestudyperiod,211(49.3%)subse- Asian:(.)
quentlydevelopedBPD; 189infants wereincludedinthe Mixed:(.)
analysisand29infantswereexcluded(Figure1).
Other:(.)
Modeofdelivery Emergency
The included infants had a median (interquartile
caesarean:(.)
range) gestational age of 25.9 (24.9–27.7) weeks and Electivecaesarean:
birthweightof769(667–930)grams(Table2).Twenty-one (.)
(11.5%) infants had early PH of which six (28.5%) subse- Spontaneousvaginal:
quentlydevelopedlatePH.Twenty-two(12%)infantshad
(.)
Instrumental:(.)
late PH. Amongst the 22 infants with late PH, pulmonary
Antenatalsteroids(atleast (.)
hypertension resolved in 10 infants, four had pulmonary
onedose)
hypertension at discharge from neonatal care and eight Pre-eclampsia (.)
diedwithpulmonaryhypertension(Figure2). Maternalsubstanceabuse (.)
ThecharacteristicsofinfantswhodevelopedearlyPH, Clinicalchorioamnionitis (.)
latePH,bothearlyandlateandnoPHhavebeendetailed EarlyPH (.)
LatePH (.)
inTable3.Theinfantswhodevelopedbothearlyandlate
PHatdeathordischarge (.)
PH had a lower (median) gestational age (24.4 weeks) Positivepressureventila- (.)
comparedtothosewhohadonlyearlyPH(25.7weeks),late tiononday
PH (24.6 weeks) or no PH (26.1 weeks, p=0.02). Further- Inhalednitricoxide (.)
more,infantswhodevelopedbothearlyandlatePHhada Inotropeadministration (.)
PDArequiringtreatment (.)
lower(median)birthweight(603g)comparedtothosewho
Cultureprovensepsis (.)
had early PH (780 g), late PH (673 g) or no PH (818 g,
SurgicalNEC (.)
p<0.001). SevereIVH (.)
SevereROP (.)
Mortality (.)
PH,pulmonaryhypertension;PDA,patentductusarteriosus.
The infants who developed late PH had a lower
gestational age (24.6 vs. 26.1 weeks, p=0.002) and lower
birthweight(642.5vs.816.5g,p<0.001)comparedtothose
whodidnothavelatePH.Theinfantswhodevelopedlate
PHweremoreoftenmechanicallyventilatedonday28after
birth compared to the ones who did not develop late
PH [100 vs. 51.9%, p<0.001; OR: 19.5 (CI: 2.6–148)]. The
infants who developed late PH had a longer median
durationofmechanicalventilationcomparedtotheinfants
withoutlatePH(53.5vs.27.5days,p<0.001)[Table4].
Eleveninfants(6%)diedinthestudypopulation.Eight
had pulmonary hypertension at death, of those eight, six
had developed PH within 28 days after birth (Figure 2).
Figure1: Flowchartofselectedcases. ThepresenceoflatePHwasindependentlyassociatedwith
330 ArattuThodikaetal.:BPDandpulmonaryhypertension
Figure2: Developmentandevolutionofpulmonaryhypertensionduringneonatalstay.
Table: DemographicsofinfantsbyearlyPH,latePH,bothearly+lateandnoPH.
Characteristics EarlyPH(n=),n(%)or LatePH(n=),n(%)or Early+latePH(n=),n(%)or NoPH(n=),n(%)or p-
median(IQR) median(IQR) median(IQR) median(IQR) Value
Gestationalage, .(.–.) .(.–.) .(.–.) .(–.) .
weeks
Birthweight,grams (–) (–) (–) (.–) <.
Birthweightzscores −.(−.to.) −.(−.to.) −.(−.to.) −.(−.to.) .
Apgaratmin (–) (–) (–) (–) .
Smallforgestational () (.) (.) (.) .
age
Sex,male (.) (.) (.) (.) .
Antenatalsteroids (.) () (.) (.) .
Pre-eclampsia (.) (.)  (.) .
Maternalsubstance (.)   (.) .
abuse
PH,pulmonaryhypertension;IQR,interquartilerange.
increasedmortality[OR:21.4(4.1–111.3),adjustedp=0.001]. before discharge or died with PH [147 (72–259) days,
Similarly,thepresenceoflatePHinsurvivinginfantswas p=0.81].Thetotalcostofstaywasnotsignificantlydifferent
independentlyassociatedwithalongerdurationofhospi- ininfantsinwhomPHresolvedbeforedischarge[£85,992
talstay[147vs.109days,adjustedp:0.03](Table5). (67,524–121,939)]comparedtotheinfantsinwhomPHdid
The total cost of stay for the 182 infants was not resolve before discharge [£148,458 (80,185–252,455),
£17,164,290 ($23,957,659). The median (IQR) total cost of p=0.07].
stayininfantswithlatePHwas£113,494(72,650–169,798)
comparedto£78,677(48,476–115,483)ininfantswithBPD,
Discussion
butnolatePHafteradjustingforgestationalage(p=0.016)
[Table5].ThemediancostofstayininfantswithBPDand
PH was approximately £35,000 higher (44% higher) WehavedemonstratedlatePHwasassociatedwithahigher
comparedtothatofinfantswithBPDwithoutPH. mortalityandalongerdurationofstaycomparedtoinfants
The median length of hospitalisation was similar in withBPDwithoutPH.Furthermore,wefoundthatthetotal
infantswhomPHresolvedbeforedischarge[147(118–189) cost of stay for infants with late PH and BPD was higher
days]comparedtotheinfantsinwhomPHdidnotresolve comparedtothosewhodidnotdeveloplatePH.
ArattuThodikaetal.:BPDandpulmonaryhypertension 331
Table: DemographicsofinfantsbylatePHstatus. withBPD,butdidnotdescribetheimpactofthisonmor-
tality[16,17].Thishighlightstheneedforearlyaswellas
Characteristics LatePH(n=), NolatePH p- regularscreeningforpulmonaryhypertensionviaechocar-
n(%)ormedian (n=),n(%)or Value
diographicassessmentininfantswithBPD.
(IQR) median(IQR)
Onestudyreportedthehealthcareutilizationofinfants
Gestationalage, .(.– .(–.) . withPHassociatedwithBPDpresentingaftertwomonths
weeks .)
of age into a BPD clinic and found that the infants were
Birthweight,grams .(.– .(.– <.
.) ) hospitalisedforalongerdurationandhadmorerespiratory
Birthweightzscores −.(−.to −.(−.to . morbiditythaninfantswithBPDbutnoPH[28].Ourstudy
.) .) reportedonthetotalcostofstaybasedonnationalaverage
Apgaratmin (–) (–) .
ininfantswithBPDandPHandtoourknowledgethisisthe
Smallforgestational (.) (.) . firststudywhichspecificallylookedintotheeffectofpul-
age
monary hypertension in infants with bronchopulmonary
Sex,male (.) (.) .
Antenatalsteroids (.) (.) . dysplasiaonhealthcarecosts.
Pre-eclampsia (.) (.) . Ourstudyhasstrengthsandsomelimitations.Inour
Maternalsubstance  (.) . study population we used echocardiography to identify
abuse pulmonaryhypertension;echocardiographyisconsidered
Positivepressure () (.) <.
tobeaneffectiveandreliablescreeningtoolfordetection
ventilationonday
PDArequiringtreat- (.) (.) . of pulmonary hypertension in infants with BPD [29]. A
ment(medical/ limitation,however,wasthattheinfantshadechocardio-
surgical) gramsatvarioustimeintervalsaccordingtoclinicalneed
Durationofinvasive .(–.) .(–) <. ratherthanatspecificintervals,butthismakesourresults
ventilation,days
generalisabletoclinicalpractice.
Cultureprovensepsis (.) (.) .
In conclusion, infants with late PH had a longer
PresenceofearlyPH (.) (.) .
SurgicalNEC (.) () . duration of hospitalization and increased mortality
SevereIVH (.) (.) . comparedtotheinfantswithoutlatePH.Thepresenceof
late PH in infants with BPD resulted in increased
PH,pulmonaryhypertension;IQR,interquartilerange;PDA,patent
healthcarecosts.
ductusarteriosus.
Our study showed that while the incidence of overall Research funding: The research was supported by the
mortalitywas6%inthestudypopulation,thepresenceof NationalInstituteforHealthResearch(NIHR)Biomedical
late PH was associated with a 36% increase in mortality. Research Centre based at Guy’s and St Thomas’ NHS
StudieshavedescribedtheassociationofPHandmortality Foundation Trust and King’s College London. The views
withanincidencerangingfrom10to38%[7,8,14,17,18,27]. expressed are those of the authors and not necessarily
Notably,amongtheeightinfantswhodiedwithpulmonary thoseoftheNHS,theNIHRortheDepartmentofHealth.
hypertension,sixofthemhaddevelopedPHwithin28days Author contributions: All authors were involved in the
(Figure2).TwostudieshaveshownthatearlyPHincreases conceptionofthestudy.FA-T,MNandABwereinvolvedin
theriskforsevereBPDanddevelopmentoflatePHininfants thedatacollection.FA-T,TDandAGwereinvolvedinthe
Table: LatePHandmortalityandtotalcostofstay.
LatePH(n=),n(%)or NolatePH(n=),n(%)or p- Oddsratio Adjusted AdjustedOR
median(IQR) median(IQR) Value (%CI) p-value (%CI)
Mortality (.) (.) <. . . .
(.–.) (.–.)
Lengthofhospital- (–) (–) . .
isation,days
Totalcostofhospital £, £, . .
stay (,–,) (,–,)
PH,pulmonaryhypertension;IQR,interquartilerange.
332 ArattuThodikaetal.:BPDandpulmonaryhypertension
analysis of the data. All authors were involved in the 12. MestanKK,CheckJ,MinturnL,YallapragadaS,FarrowKN,LiuX,
preparation of the manuscript and approved the final etal.Placentalpathologicchangesofmaternalvascular
underperfusioninbronchopulmonarydysplasiaandpulmonary
version.
hypertension.Placenta2014;35:570–4.
Competinginterests:Authorsstatenoconflictofinterest.
13. HansenAR,BarnésCM,FolkmanJ,McElrathTF.Maternal
Informedconsent:Notapplicable.
preeclampsiapredictsthedevelopmentofbronchopulmonary
Ethicalapproval:ThestudywasregisteredwiththeKing’s dysplasia.JPediatr2010;156:532–6.
CollegeHospitalNHSFoundationTrustClinicalGovernance 14. AnHS,BaeEJ,KimGB,KwonBS,BeakJS,KimEK,etal.Pulmonary
and Audit Department and did not require informed hypertensioninpreterminfantswithbronchopulmonary
dysplasia.KoreanCircJ2010;40:131–6.
parentalconsent.
15. KrishnanU,FeinsteinJA,AdatiaI,AustinED,MullenMP,Hopper
RK,etal.Evaluationandmanagementofpulmonaryhypertension
References inchildrenwithbronchopulmonarydysplasia.JPediatr2017;188:
24–34.
16. ShethS,GotoL,BhandariV,AbrahamB,MowesA.Factors
1. SanthakumaranS,StatnikovY,GrayD,BattersbyC,AshbyD, associatedwithdevelopmentofearlyandlatepulmonary
ModiN.Survivalofverypreterminfantsadmittedtoneonatalcare hypertensioninpreterminfantswithbronchopulmonary
inEngland2008–2014:timetrendsandregionalvariation.Arch dysplasia.JPerinatol2020;40:138–48.
DisChildFetalNeonatalEd2018;103:F208–15. 17. MouraniPM,SontagMK,YounoszaiA,MillerJI,KinsellaJP,Baker
2. StollBJ,HansenNI,BellEF,WalshMC,CarloWA,ShankaranS, CD,etal.Earlypulmonaryvasculardiseaseinpreterminfantsat
etal.Trendsincarepractices,morbidity,andmortalityof riskforbronchopulmonarydysplasia.AmJRespirCritCareMed
extremelypretermneonates,1993–2012.JAmMedAssoc2015; 2015;191:87–95.
314:1039. 18. KhemaniE,McElhinneyDB,RheinL,AndradeO,LacroRV,Thomas
3. SiffelC,KistlerKD,LewisJFM,SardaSP.Globalincidenceof KC,etal.Pulmonaryarteryhypertensioninformerlypremature
bronchopulmonarydysplasiaamongextremelypreterminfants: infantswithbronchopulmonarydysplasia:clinicalfeaturesand
asystematicliteraturereview.JMaternFetalNeonatalMed2021; outcomesinthesurfactantera.Pediatrics2007;120:1260–9.
34:1721–31. 19. MirzaH,ZieglerJ,FordS,PadburyJ,TuckerR,LaptookA.
4. ZivanovicS,PeacockJ,Alcazar-ParisM,LoJW,LuntA,MarlowN, Pulmonaryhypertensioninpreterminfants:prevalenceand
etal.Lateoutcomesofarandomizedtrialofhigh-frequency associationwithbronchopulmonarydysplasia.JPediatr2014;
oscillationinneonates.NEnglJMed2014;370:1121–30. 165:909–14.
5. AltitG,BhombalS,HopperRK,TacyTA,FeinsteinJ.Deathor 20. DelCerroMJ,SabatéRotésA,CartónA,DeirosL,BretM,Cordeiro
resolution:the“naturalhistory”ofpulmonaryhypertensionin M,etal.Pulmonaryhypertensioninbronchopulmonary
bronchopulmonarydysplasia.JPerinatol2019;39:415–25. dysplasia:clinicalfindings,cardiovascularanomaliesand
6. Al-GhanemG,ShahP,ThomasS,BanfieldL,ElHelouS,FuschC, outcomes.PediatrPulmonol2014;49:49–59.
etal.Bronchopulmonarydysplasiaandpulmonaryhypertension: 21. KwonHW,KimH-S,AnHS,KwonBS,KimGB,ShinSH,etal.Long-
ameta-analysis.JPerinatol2017;37:414–9. termoutcomesofpulmonaryhypertensioninpreterminfants
7. BhatR,SalasAA,FosterC,CarloWA,AmbalavananN.Prospective withbronchopulmonarydysplasia.Neonatology2016;110:181–9.
analysisofpulmonaryhypertensioninextremelylowbirthweight 22. JobeAH,BancalariE.Bronchopulmonarydysplasia.AmJRespir
infants.Pediatrics2012;129:e682–9. CritCareMed2001;163:1723–9.
8. SlaughterJL,PakrashiT,JonesDE,SouthAP,ShahTA. 23. PoindexterBB,FengR,SchmidtB,AschnerJL,BallardRA,Hamvas
Echocardiographicdetectionofpulmonaryhypertensionin A,etal.Comparisonsandlimitationsofcurrentdefinitionsof
extremelylowbirthweightinfantswithbronchopulmonary bronchopulmonarydysplasiafortheprematurityandrespiratory
dysplasiarequiringprolongedpositivepressureventilation.J outcomesprogram.AnnAmThoracSoc2015;12:1822–30.
Perinatol2011;31:635–40. 24. PapileL-A,BursteinJ,BursteinR,KofflerH.Incidenceand
9. JakkulaM,LeCrasTD,GebbS,HirthKP,TuderRM,VoelkelNF, evolutionofsubependymalandintraventricularhemorrhage:a
etal.Inhibitionofangiogenesisdecreasesalveolarizationinthe studyofinfantswithbirthweightslessthan1,500gm.JPediatr
developingratlung.AmJPhysiolLungCellMolPhysiol2000;279: 1978;92:529–34.
L600–7. 25. RoyalCollegeofObstetriciansandGynaecologists(RCOG).
10. MouraniPM,AbmanSH.Pulmonaryhypertensionandvascular Small-for-gestational-agefetus,investigationandmanagement
abnormalitiesinbronchopulmonarydysplasia.ClinPerinatol (green-topguidelineno.31).London:RCOG;2002(update2013).
2015;42:839–55. Availablefrom:www.rcog.org.uk/en/guidelines-research-
11. CheckJ,GotteinerN,LiuX,SuE,PortaN,SteinhornR,etal.Fetal services/guidelines/gtg31/.
growthrestrictionandpulmonaryhypertensioninpremature 26. DepartmentofHealth:referencecostsguidance2015–2016;
infantswithbronchopulmonarydysplasia.JPerinatol2013;33: nationalscheduleofreferencecosts–mainschedule.London,
553–7. UK:DepartmentofHealthandSocialCare;2016:1–59pp.
ArattuThodikaetal.:BPDandpulmonaryhypertension 333
27. AswaniR,HaymanL,NicholsG,LucianoAA,AmankwahEK, preterminfantswithpulmonaryhypertension.JPerinatol2013;
LeshkoJL,etal.Oxygenrequirementasascreeningtoolforthe 33:543–7.
detectionoflatepulmonaryhypertensioninextremelylowbirth 29. NagiubM,LeeS,GuglaniL.Echocardiographicassessmentof
weightinfants.CardiolYoung2016;26:521–7. pulmonaryhypertensionininfantswithbronchopulmonary
28. StuartBD,SekarP,CoulsonJD,ChoiSE,McGrath-MorrowSA, dysplasia:systematicreviewofliteratureandaproposed
CollacoJM.Health-careutilizationandrespiratorymorbiditiesin algorithmforassessment.Echocardiography2015;32:819–33.
